Location History:
- Newtown, PA (US) (2017 - 2018)
- Madison, NJ (US) (2022)
Company Filing History:
3 out of 549 
1 out of 96 
Years Active: 2017-2022
Title: Michael D Amatangelo: Innovator in Cancer Treatment
Introduction
Michael D Amatangelo is a prominent inventor based in Madison, NJ (US), known for his significant contributions to cancer treatment. With a total of 3 patents, he has made strides in developing innovative therapies aimed at improving patient outcomes in oncology.
Latest Patents
Among his latest patents, Amatangelo has developed a combination therapy for the treatment of cancer. This method involves administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab. Additionally, he has provided methods for treating and managing cancers that include the administration of Compound A in combination with daratumumab and dexamethasone. Another notable patent focuses on methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
Career Highlights
Throughout his career, Amatangelo has worked with leading companies in the pharmaceutical industry, including Celgene Corporation and Agios Pharmaceuticals, Inc. His work has been instrumental in advancing cancer therapies and improving treatment protocols.
Collaborations
Amatangelo has collaborated with notable professionals in the field, including Anjan Thakurta and Chad Bjorklund. These partnerships have contributed to the development of innovative solutions in cancer treatment.
Conclusion
Michael D Amatangelo's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing healthcare solutions for patients.